A single nucleotide polymorphism in the BART promoter region of Epstein-Barr virus isolated from nasopharyngeal cancer cells

Biochem Biophys Res Commun. 2019 Dec 3;520(2):373-378. doi: 10.1016/j.bbrc.2019.10.028. Epub 2019 Oct 10.

Abstract

Epstein-Barr virus (EBV) encodes BamHIA rightward transcript (BART) microRNAs (miRNAs). These miRNAs are expressed at high levels in epithelial tumors, such as nasopharyngeal carcinoma (NPC). BART miRNAs play important roles in EBV-associated malignancies, however, the reason for their high expression in NPC is unclear. We performed multiple sequence alignment of six completely sequenced EBV strains: Akata, YCCEL1, SNU719, C666-1, Mutu I, and M81. A single-nucleotide deletion was identified at the promoter region of BART. The luciferase assay suggested that this single-nucleotide polymorphism (SNP) significantly increased BART promoter activity. In addition to deletion, substitution at the same site also increased BART promoter activity. Analysis of the 170 EBV genome sequences from NPC and EBV-associated gastric cancers revealed that the frequency of this SNP was associated with NPC incidence and this SNP was found to be accumulated in the BART promoter region. Overall, our results suggested that this SNP should enhance BART promoter activity and thus, might contribute to the development of EBV-associated epithelial malignancies.

Keywords: BART miRNA; Epstein-Barr virus; Nasopharyngeal carcinoma; Single nucleotide polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Epstein-Barr Virus Infections / virology
  • Gene Expression Regulation, Viral
  • Herpesvirus 4, Human / genetics*
  • Herpesvirus 4, Human / pathogenicity
  • Humans
  • MicroRNAs / genetics
  • Nasopharyngeal Carcinoma / virology*
  • Nasopharyngeal Neoplasms / virology*
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic

Substances

  • MicroRNAs